Papers - Tasaka Sadatomo
-
Pathophysiology of ARDS: What is the current understanding of pathophysiology of ARDS? ed., Tasaka S. Acute Respiratory Distress Syndrome. Advances in Diagnostic Tools and Disease Management.
Tasaka S.
Springer Nature 33 - 52 2022
-
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study).
Tanzawa S, Makiguchi T, Tasaka S, Inaba M, Ochiai R, Nakamura J, Inoue K, Kishikawa T, Nakashima M, Fujiwara K, Kohyama T, Ishida H, Kuyama S, Miyazawa N, Nakamura T, Miyawaki H, Oda N, Ishikawa N, Morinaga R, Kusaka K, Miyamoto Y, Yokoyama T, Matsumoto C, Tsuda T, Ushijima S, Shibata K, Shibayama T, Bessho A, Kaira K, Misumi T, Shiraishi K, Matsutani N, Seki N
Therapeutic advances in medical oncology 14 17588359221116603 2022
-
Epidemiological investigation of the factors affecting the COVID-19 case fatality rate
Tsuchiya Junichiro, Saito Norihiro, Itoga Masamichi, Tasaka Sadatomo, Kayaba Hiroyuki
Hirosaki Medical Journal 72 ( 1-4 ) 34 - 42 2022
-
クライオバイオプシーで診断した肺クリプトコッカス症の一例．
小田切 遥，牧口友紀，福島高志，石岡佳子，糸賀正道，田中寿志，當麻景章，黒瀬 顕，田坂定智．
気管支学 44 ( 5 ) 325 - 350 2022
-
急性呼吸促迫症候群（ARDS）．
田坂定智
門脇 孝，小室一成，宮地良樹 監修．日常診療に活かす診療ガイドラインUP-TO-DATE 2022-2023メディカルレビュー社 143 - 145 2022
-
生物学的製剤使用時に注意すべき肺真菌症
田坂定智
呼吸器内科 41 288 - 294 2022
-
１ページでわかる内科疾患の診療ノート：気管支喘息．
糸賀正道，田坂定智．
内科 129 539 - 542 2022
-
健診異常で肺野に単発の結節影を指摘された患者が受診されました．どうすればよいでしょうか？
牧口友紀，田坂定智
内科 130 370 - 371 2022
-
細菌性肺炎
當麻景章，田坂定智
カレントテラピー 40 1048 - 1053 2022
-
急性呼吸窮迫症候群（ARDS）
田坂定智
日本医事新報 5141 38 - 38 2022
-
呼吸数，測ってますか？
田坂定智
Medical Practice 39 ( 12 ) 1903 - 1903 2022
-
急性間質性肺炎．
田坂定智
弦間昭彦 編．最新ガイドラインに基づく呼吸器疾患診療指針2023-2024 149 - 154 2022
-
多様化するタバコ問題の現状
田坂定智
モダンメディア 68 ( 12 ) 509 - 514 2022
-
How to improve lung auscultation in daily practice
Cho Sumito, Tasaka Sadatomo
The Journal of the Japan Society for Respiratory Care and Rehabilitation 30 ( 1 ) 23 - 23 2021.12
-
Characteristics of central nervous system progression in non-small cell lung cancer treated with crizotinib or alectinib.
Sakamoto H, Yanagitani N, Manabe R, Tsugitomi R, Ogusu S, Tozuka T, Yoshida H, Amino Y, Ariyasu R, Uchibori K, Kitazono S, Tasaka S, Nishio M
Cancer reports (Hoboken, N.J.) 4 ( 6 ) e1414 2021.12
-
Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case report.
Makiguchi T, Tanaka H, Kamata K, Taima K, Kurose A, Tasaka S
Thoracic cancer 12 ( 20 ) 2811 - 2814 2021.10
-
Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case report.
Tomonori Makiguchi, Hisashi Tanaka, Kosuke Kamata, Kageaki Taima, Akira Kurose, Sadatomo Tasaka
Thoracic cancer 12 ( 20 ) 2811 - 2814 2021.8
-
本邦で検証が進む新型たばこ関連肺障害
田坂 定智
週刊医学界新聞 ( 第3429号 ) 2021.7
-
The relationship between evolving sarcopenia and efficacy of immune checkpoint inhibitor in non-small cell lung cancer patients.
Makiguchi T, Tanaka H, Taima K, Tatsuo S, Iida S, Kakeda S, Tasaka S.
JCSM Clin Rep 2021.7
-
The relationship between evolving sarcopenia and efficacy of immune checkpoint inhibitor in non-small cell lung cancer patients
2021.7